COMPANY PROFILE

GensKey / 金匙医学

Explore full profile

Beijing pathogen mNGS / infectious-disease molecular Dx OEM

ChinaFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2020

Total funding $50–100M Disclosed equity funding

Unlock exact values

About GensKey / 金匙医学

Beijing pathogen metagenomic NGS / infectious-disease molecular Dx OEM (GensKey / 金匙医学) supplying mNGS/tNGS reagents, instruments and lab services. Founded in 2017 with Changping Life Science Park R&D, Tianjin Wuqing GMP plant and Beijing·Shanghai·Guangzhou·Tianjin clinical labs; headquarters framed at city-level Beijing rather than Dongcheng District. Conservative mid-size headcount band (near-400 class marketing vs thinner legal-entity filings). Mid-size China NGS leftover peer beyond Hybribio, GeneCast and YuceBio; soft-skip MatriDx size and Vision Medicals employees-only peers.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: China
Open positions: None listed
Dealroom signal: 21.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Testing, Biotechnology, Genetics and genomics, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Jun 2021	$14M	$55M	Taiping Asset Management	—
SERIES COther financing	Nov 2020	$34M	$138M	Legend Capital · Apricot Capital · YuanBio Venture Capital · Huagai Capital	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

GensKey / 金匙医学 website traffic

Latest recorded traffic for GensKey / 金匙医学 is 3K monthly website visits, up 1900% over the last three months.

Latest monthly visits3K 3-month web change+1900%

Monthly website visitsMay 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CDCNA DiagnosticsA molecular diagnostics company developing novel diagnostic tests for a spectrum of complex diseases	Calgary, Canada	Operational	—	$4.3M	—
IXIxLayerDigital health company focused on improving the delivery of lab testing	San Francisco, United States	Operational
GHGenesis HealthcareA privately-owned Japanese genetic testing and research company	Tokyo, Japan	Operational
BIBillionToOneThe only genetic testing platform that accurately and efficiently detects and measures disease at the molecular level	Menlo Park, United States	Operational
AKAKESOgenBiomarker, genomics, and pharmacogenomics contract research organization	Peachtree Corners, United States	Acquired
HEHelixThe leading population genomics company working at the intersection of clinical care, research, and genomics	San Mateo, United States	Operational
ANAnnoroadA leading developer and marketer on genomic innovation technologies for research and clinical market	Dongcheng District, China	Operational
MLMedGenome LabsA genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome	Foster City, United States	Operational